Literature DB >> 22120711

Reexpression of oncoprotein MafB in proliferative β-cells and Men1 insulinomas in mouse.

J Lu1, Z Hamze, R Bonnavion, N Herath, C Pouponnot, F Assade, S Fontanière, P Bertolino, M Cordier-Bussat, C X Zhang.   

Abstract

MafB, a member of the large Maf transcription factor family, is essential for the embryonic and terminal differentiation of pancreatic α- and β-cells. However, the role of MafB in the control of adult islet-cell proliferation remains unknown. Considering its oncogenic potential in several other tissues, we investigated the possible alteration of its expression in adult mouse β-cells under different conditions of proliferation. We found that MafB, in general silenced in these cells, was reexpressed in ∼30% of adaptive β-cells both in gestational female mice and in mice fed with a high-fat diet. Importantly, reactivated MafB expression was also observed in the early β-cell lesions and insulinomas that developed in β-cell specific Men1 mutant mice, appearing in >80% of β-cells in hyperplasic or dysplastic islets from the mutant mice >4 months of age. Moreover, MafB expression could be induced by glucose stimulation in INS-1 rat insulinoma cells. The induction was further reinforced following Men1 knockdown by siRNA. Furthermore, MafB overexpression in cultured βTC3 cells enhanced cell foci formation both in culture medium and on soft agar, accompanied with the increased expression of Cyclin B1 and D2. Conversely, MafB downregulation by siRNA transfection reduced BrdU incorporation in INS-1E cells. Taken together, our data reveal that Men1 inactivation leads to MafB reexpression in mouse β-cells in vivo, and provides evidence that deregulated ectopic MafB expression may have a hitherto unknown role in adult β-cell proliferation and Men1-related tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22120711     DOI: 10.1038/onc.2011.538

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  15 in total

1.  The embryonic transcription factor Hlxb9 is a menin interacting partner that controls pancreatic β-cell proliferation and the expression of insulin regulators.

Authors:  Kerong Shi; Vaishali I Parekh; Swarnava Roy; Shruti S Desai; Sunita K Agarwal
Journal:  Endocr Relat Cancer       Date:  2013-02-18       Impact factor: 5.678

2.  Pdx1 maintains β cell identity and function by repressing an α cell program.

Authors:  Tao Gao; Brian McKenna; Changhong Li; Maximilian Reichert; James Nguyen; Tarjinder Singh; Chenghua Yang; Archana Pannikar; Nicolai Doliba; Tingting Zhang; Doris A Stoffers; Helena Edlund; Franz Matschinsky; Roland Stein; Ben Z Stanger
Journal:  Cell Metab       Date:  2014-02-04       Impact factor: 27.287

Review 3.  Twenty years of menin: emerging opportunities for restoration of transcriptional regulation in MEN1.

Authors:  Koen M A Dreijerink; H T Marc Timmers; Myles Brown
Journal:  Endocr Relat Cancer       Date:  2017-08-15       Impact factor: 5.678

4.  Altered MENIN expression disrupts the MAFA differentiation pathway in insulinoma.

Authors:  Z Hamze; C Vercherat; A Bernigaud-Lacheretz; W Bazzi; R Bonnavion; J Lu; A Calender; C Pouponnot; P Bertolino; C Roche; R Stein; J Y Scoazec; C X Zhang; M Cordier-Bussat
Journal:  Endocr Relat Cancer       Date:  2013-10-24       Impact factor: 5.678

5.  Growth arrest specific protein (GAS) 6: a role in the regulation of proliferation and functional capacity of the perinatal rat beta cell.

Authors:  T N Haase; M Rasmussen; C A M Jaksch; L W Gaarn; C K Petersen; N Billestrup; J H Nielsen
Journal:  Diabetologia       Date:  2013-01-19       Impact factor: 10.122

6.  The deubiquitinase USP7 stabilizes Maf proteins to promote myeloma cell survival.

Authors:  Yuanming He; Siyu Wang; Jiefei Tong; Shuoyi Jiang; Ye Yang; Zubin Zhang; Yujia Xu; Yuanying Zeng; Biyin Cao; Michael F Moran; Xinliang Mao
Journal:  J Biol Chem       Date:  2019-12-10       Impact factor: 5.157

7.  Both PAX4 and MAFA are expressed in a substantial proportion of normal human pancreatic alpha cells and deregulated in patients with type 2 diabetes.

Authors:  Rémy Bonnavion; Rami Jaafar; Julie Kerr-Conte; Fouzia Assade; Esther van Stralen; Emmanuelle Leteurtre; Célio Pouponnot; Sofia Gargani; François Pattou; Philippe Bertolino; Martine Cordier-Bussat; Jieli Lu; Chang Xian Zhang
Journal:  PLoS One       Date:  2013-08-27       Impact factor: 3.240

8.  Functional Defects From Endocrine Disease-Associated Mutations in HLXB9 and Its Interacting Partner, NONO.

Authors:  Sampada S Kharade; Vaishali I Parekh; Sunita K Agarwal
Journal:  Endocrinology       Date:  2018-02-01       Impact factor: 4.736

Review 9.  Multiple Endocrine Neoplasia Type 1: Latest Insights.

Authors:  Maria Luisa Brandi; Sunita K Agarwal; Nancy D Perrier; Kate E Lines; Gerlof D Valk; Rajesh V Thakker
Journal:  Endocr Rev       Date:  2021-03-15       Impact factor: 19.871

10.  Gestational Diabetes Mellitus From Inactivation of Prolactin Receptor and MafB in Islet β-Cells.

Authors:  Ronadip R Banerjee; Holly A Cyphert; Emily M Walker; Harini Chakravarthy; Heshan Peiris; Xueying Gu; Yinghua Liu; Elizabeth Conrad; Lisa Goodrich; Roland W Stein; Seung K Kim
Journal:  Diabetes       Date:  2016-05-23       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.